| Literature DB >> 30880155 |
Nicholas B Struntz1, Andrew Chen1, Anja Deutzmann2, Robert M Wilson1, Eric Stefan3, Helen L Evans1, Maricela A Ramirez4, Tong Liang4, Francisco Caballero3, Mattheus H E Wildschut3, Dylan V Neel3, David B Freeman5, Marius S Pop5, Marie McConkey6, Sandrine Muller7, Brice H Curtin1, Hanna Tseng3, Kristen R Frombach3, Vincent L Butty8, Stuart S Levine8, Clementine Feau7, Sarah Elmiligy9, Jiyoung A Hong10, Timothy A Lewis7, Amedeo Vetere7, Paul A Clemons7, Scott E Malstrom9, Benjamin L Ebert6, Charles Y Lin11, Dean W Felsher2, Angela N Koehler12.
Abstract
The transcription factor Max is a basic-helix-loop-helix leucine zipper (bHLHLZ) protein that forms homodimers or interacts with other bHLHLZ proteins, including Myc and Mxd proteins. Among this dynamic network of interactions, the Myc/Max heterodimer has crucial roles in regulating normal cellular processes, but its transcriptional activity is deregulated in a majority of human cancers. Despite this significance, the arsenal of high-quality chemical probes to interrogate these proteins remains limited. We used small molecule microarrays to identify compounds that bind Max in a mechanistically unbiased manner. We discovered the asymmetric polycyclic lactam, KI-MS2-008, which stabilizes the Max homodimer while reducing Myc protein and Myc-regulated transcript levels. KI-MS2-008 also decreases viable cancer cell growth in a Myc-dependent manner and suppresses tumor growth in vivo. This approach demonstrates the feasibility of modulating Max with small molecules and supports altering Max dimerization as an alternative approach to targeting Myc.Entities:
Keywords: Max; Myc; chemical probe; small molecule microarray; transcription
Mesh:
Substances:
Year: 2019 PMID: 30880155 DOI: 10.1016/j.chembiol.2019.02.009
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116